3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
6
OTHER_GOV
3
UNKNOWN
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Solitary Pulmonary Nodule
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Interventions
Radiotherapy, Intensity-Modulated
3
Radiotherapy
2
Epirubicin
2
Cytarabine
2
pirarubicin
1
durvalumab
1
aclacinomycins
1
Temozolomide
1
Sorafenib
1
Radiotherapy, Adjuvant
1
Radiation Dose Hypofractionation
1
Povidone-Iodine
1
Pleurodesis
1
Paclitaxel
1
Nutrition Assessment
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylene Blue
1
Indocyanine Green
1
Equipment and Supplies
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Daunorubicin
1
Cyclophosphamide
1
Cabergoline
1
CAG protocol
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
UNKNOWN
×
Methylene Blue
×
Clear all
NCT04056923
2019-08-14
3D Printing for Nodule Localization
GuangdongPPH
Phase NA
Completed
47 enrolled